A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis-Reference-Cited by-同舟云学术

A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis

Published:2019-11-25 Issue:3 Volume:267 Page:802-811
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Tavazzi Eleonora,Bergsland Niels,Kuhle Jens,Jakimovski Dejan,Ramanathan Murali,Maceski Aleksandra M.,Tomic Davorka,Hagemeier Jesper,Kropshofer Harald,Leppert David,Dwyer Michael G.,Weinstock-Guttman Bianca,Benedict Ralph H. B.,Zivadinov Robert^ORCID

Funder

Novartis Pharma AG, Basel, Switzerland

Swiss National Research Foundation

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,Neurology

Link

http://link.springer.com/content/pdf/10.1007/s00415-019-09643-z.pdf

Reference37 articles.

1. Barro C, Benkert P, Disanto G, Tsagkas C, Amann M, Naegelin Y, Leppert D, Gobbi C, Granziera C, Yaldizli O, Michalak Z, Wuerfel J, Kappos L, Parmar K, Kuhle J (2018) Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis. Brain 141:2382–2391

2. Benedict RH, DeLuca J, Phillips G, LaRocca N, Hudson LD, Rudick R, Multiple Sclerosis Outcome Assessments C (2017) Validity of the symbol digit modalities test as a cognition performance outcome measure for multiple sclerosis. Mult Scler 23:721–733

3. Berger T (2017) Biomarkers in the evolution of multiple sclerosis. Neurodegener Dis Manag 7:3–6

4. Disanto G, Barro C, Benkert P, Naegelin Y, Schadelin S, Giardiello A, Zecca C, Blennow K, Zetterberg H, Leppert D, Kappos L, Gobbi C, Kuhle J, Swiss Multiple Sclerosis Cohort Study G (2017) Serum Neurofilament light: a biomarker of neuronal damage in multiple sclerosis. Ann Neurol 81:857–870

5. Dwyer MG, Bergsland N, Ramasamy DP, Jakimovski D, Weinstock-Guttman B, Zivadinov R (2018) Atrophied brain lesion volume: a new imaging biomarker in multiple sclerosis. J Neuroimaging 28:490–495

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Symbol Digit Modalities Test in progressive multiple sclerosis;Neurologia i Neurochirurgia Polska;2024-06-24

2. Glial cell injury and atrophied lesion volume as measures of chronic multiple sclerosis inflammation;Journal of the Neurological Sciences;2024-06

3. Predictors of multiple sclerosis progression: A systematic review of conventional magnetic resonance imaging studies;PLOS ONE;2024-04-16

4. Image harmonization improves consistency of intra-rater delineations of MS lesions in heterogeneous MRI;Neuroimage: Reports;2024-03

5. Current knowledge on multiple sclerosis pathophysiology, disability progression assessment and treatment options, and the role of autologous hematopoietic stem cell transplantation;Autoimmunity Reviews;2024-02